Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

European Study on the Attitude of Psychiatrists Towards Their Patients (Eustigma)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04644978
Recruitment Status : Recruiting
First Posted : November 25, 2020
Last Update Posted : November 25, 2020
Sponsor:
Information provided by (Responsible Party):
Dorottya Ori, Semmelweis University

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

Background: Many people think that people with mental disorders might be dangerous or unpredictable. These patients face various sources of disadvantages and experience discrimination on job interviews, in education, and housing. Mental health-related stigma (MHS) occurs not only within the public community, it is a growing issue among professionals as well.

Aim: We designed a prospective, observational, multi-centre, international study of 35 European countries to investigate the MHS among medical specialists and trainees in the field of general adult and child and adolescent psychiatry.

Methods: An internet-based, anonymous survey will measure the stigmatizing attitude by using the local version of the Opening Minds Stigma Scale for Health Care Providers.

Presentation of the Results: The results of the research will be published in an international peer-reviewed journal. Furthermore, we will present the results on national and international conferences.


Condition or disease Intervention/treatment
Mental Illness Stigmatization Other: anonymous online survey

Show Show detailed description
Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 5000 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: European Study on the Attitude of Psychiatrists Towards Their Patients
Actual Study Start Date : July 29, 2020
Estimated Primary Completion Date : July 1, 2021
Estimated Study Completion Date : December 31, 2021

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
Trainees and specialists in child and adult psychiatry
The responder must be a practising specialist or trainee in psychiatry or child and adolescent psychiatry in the participating European countries on the basis of his / her own declaration. Responders could provide their consent by choosing "I agree" on the website, after reading the information leaflet and the informed consent form.
 Other: anonymous online survey
An online questionnaire will be provided for the participants of our study. Participation in the study is voluntary and it can be terminated at any time without having to give any reasons.


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. stigmatising attitude [ Time Frame: Baseline ]

    The main questionnaire is the Opening Minds Stigma Scale for Health Care Providers (OMS-HC) which is a self-report questionnaire that contains 15 statements describing feelings and opinions about people with mental health problems. . In the survey, the subjects indicate on a 5-point Likert scale (1 = "strongly disagree" to 5 = "strongly agree") the extent they identify themselves with the given statement.

    The overall stigmatising attitude of the participants is described with the total score of the scale (minimum of 15, and a maximum of 75 points). Besides the total score, three dimensions can be calculated by evaluating the three subscales of the questionnaire (Attitude, Disclosure and Help-seeking, and Social Distance).

    Higher scores on a subscale and higher total scores reflect a more stigmatising attitude.



Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   24 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Practising specialists and trainees in adult psychiatry or child and adolescent psychiatry who work in the participating European countries
Criteria

Inclusion Criteria:

  • The responder must be a practising specialist or trainee in psychiatry or child and adolescent psychiatry in one of the participating countries on the basis of his / her own declaration.
  • Responders could provide their consent by choosing "I agree" on the website, after reading the information leaflet and the informed consent form. Only those participants will be able to complete the online survey who chose "I agree" on the website.

Exclusion Criteria:

  • The choice of "I do not agree" option of the participant on the website after reading the informed consent form. The responder will be guided automatically to the end of the survey.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04644978


Contacts
Layout table for location contacts
Contact: Dorottya Ori, MD +36202116042 oridorottya@gmail.com
Contact: Zsuzsa Győrffy, PhD gyorffy.zsuzsa.mail@gmail.com

Locations
Show Show 35 study locations
Sponsors and Collaborators
Semmelweis University
Investigators
Layout table for investigator information
Principal Investigator: Dorottya Ori, MD Vadaskert Child and Adolescent Psychiatric Hospital, Budapest, Hungary
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Dorottya Ori, MD, Semmelweis University
ClinicalTrials.gov Identifier: NCT04644978    
Other Study ID Numbers: Eustigma - v. 1.0
First Posted: November 25, 2020    Key Record Dates
Last Update Posted: November 25, 2020
Last Verified: November 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Dorottya Ori, Semmelweis University:
Stigma
Mental health related stigma
Stigmatising attitude
Mental health problems
 Survey
Psychiatry
Psychiatrist
Additional relevant MeSH terms:
Layout table for MeSH terms
Mental Disorders